Main Menu

Acer Therapeutics Inc.


Rigrodsky Law, P.A. is investigating Acer Therapeutics Inc. (“Acer”) regarding possible breaches of fiduciary duties and other violations of law related to Acer’s agreement to be acquired by Zevra Therapeutics, Inc. (“Zevra”).  Under the terms of the agreement, Acer shareholders will receive 0.121 shares of Zevra’s common stock for each share of Acer’s common stock owned.

Join This Action

Alternatively, you may upload your transactions using the upload button below or email them to

Draw your signature below using your mouse* [Clear]

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of signing: 06/15/2024

* Indicates a required field.

Back to Page